ICD-10-CM Billable Code

T43.625

Adverse effect of amphetamines

Clinical Classification Guidelines

Medical Intelligence & Overview

ICD-10 code T43.625 refers to adverse effects resulting from the use of amphetamines. Amphetamines are stimulant drugs that can have therapeutic use but also pose risks when misused or taken in excessive amounts. These adverse effects can vary from mild side effects to severe health complications, emphasizing the importance of understanding the potential risks associated with these drugs.

Causes & Symptoms

Clinical Causes: Misuse or abuse of prescription amphetamines or illicit amphetamine products. Taking higher doses than prescribed or recommended. Prolonged use without medical supervision. Combining amphetamines with other stimulants or substances such as alcohol and medications.

Key Symptoms: Increased heart rate (tachycardia) Elevated blood pressure Insomnia or sleep disturbances Anxiety, agitation, or restlessness Dilated pupils Loss of appetite Headaches Dizziness or lightheadedness Nausea or vomiting Tremors or muscle twitching Potential hallucinations or psychosis in severe cases Skin complications such as rashes or sores from overuse Chest pain or palpitations Dependence and withdrawal symptoms upon cessation

Diagnostic & Treatment

Diagnosis Path: Diagnosing adverse effects of amphetamine use involves a comprehensive medical history review, physical examination, and laboratory assessments. Blood tests might be used to detect the presence of amphetamines, and healthcare providers will evaluate symptoms and medication history to determine if they relate to amphetamine intake. Toxicology screenings can confirm recent use and assist in ruling out other causes of symptoms.

Treatment Protocols: Treating adverse effects from amphetamine use depends on the severity and specific symptoms experienced. Approaches may include:

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is T43.625 a billable ICD-10 code?
Yes, T43.625 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report T43.625?
Clinical documentation must specify the nature of Adverse effect of amphetamines and any associated comorbidities for accurate reporting.

Cite this Clinical Reference